Mometasone vs Budesonide in CRS With Polyposis
Randomized Controled Double-blinded Study Comparing Mometasone Nasal Spray to Budesonide Irrigations in Patients With Chronic Rhinosinusitis With Nasal Polyposis
Sponsor: Université de Sherbrooke
Terminated
Difficulty with recruitment
Other terminated trials from Université de Sherbrooke
A PHASE3 clinical study on Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis, this trial is terminated or withdrawn. The trial is conducted by Université de Sherbrooke and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jan 2021 — Sep 2022 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Jun 2019 — Dec 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Université de Sherbrooke
For direct contact, visit the study record on ClinicalTrials.gov .